Kinfo
TransMedics Group Inc. logo

TransMedics Group Inc.

TMDXNASDAQHealthcare·US · USD
$66.39
-0.90 (-1.34%)
Close · 2026-06-30

Price

Key statistics

Valuation
Market cap2.37B USD
Enterprise value2.77B USD
Trailing P/E15.66
Forward P/E21.25
PEG ratio-0.22
Price / sales3.72
Price / book4.79
Profitability
Gross margin58.16%
Operating margin7.65%
Profit margin27.04%
Return on assets5.20%
Return on equity45.22%
Income (TTM)
Revenue635.89M USD
Gross profit375.74M USD
EBITDA139.03M USD
Net income171.92M USD
Diluted EPS$4.37
Rev. growth (YoY)21.20%
Balance sheet
Total cash461.74M USD
Total debt863.41M USD
Debt / equity174.78
Current ratio6.74
Book value / share$14.30
Cash flow (TTM)
Operating cash flow220.23M USD
Levered free cash flow108.82M USD
Shares & price
Shares outstanding34.55M
Float33.43M
Held by institutions110.00%
Beta1.88
50-day MA$80.47
200-day MA$114.27
52-week high$156.00
52-week low$60.11
Dividends
Forward rate
$0.00
Yield
0.00%
Payout ratio
0.00%
Frequency
Unknown
Earnings (EPS)
DateEst.ActualSurprise2026-06-090.480.22−54.17%2026-05-272.912.90−0.34%2026-05-050.610.30−50.82%2026-02-240.370.53+43.24%2026-02-100.961.00+4.17%
About TransMedics Group Inc.

TransMedics Group Inc. is a commercial-stage medical technology company specializing in advanced systems and services for solid organ transplantation. Headquartered in Andover, Massachusetts, it focuses on improving the preservation, assessment, and transport of donor hearts, lungs, and livers for patients with end-stage organ failure. The company’s core platform, the Organ Care System, is a portable normothermic perfusion technology that keeps donor organs functioning in a near-physiologic state outside the body, enabling clinicians to evaluate and optimize organ quality prior to transplant. TransMedics combines this device platform with a service-led model that includes its National OCS Program, offering end-to-end organ retrieval, clinical management, logistics coordination, and dedicated transportation for transplant centers across the United States. Operating in the high-acuity transplant ecosystem, TransMedics plays a critical role in organ transplant workflows by helping transplant programs increase organ utilization and support complex heart, lung, and liver procedures through integrated technology and clinical services.

Sector
Healthcare
Industry
Medical Devices
CEO
Dr. Waleed H. Hassanein M.D.
Employees
898
Headquarters
Andover, MA, United States

Frequently asked questions about TransMedics Group Inc.